Advertisement
Screener

IDEAYA Biosciences, Inc. (IDYA) Cash Flow Breakdown

IDEAYA Biosciences, Inc. Cash Flow Breakdown

Cash flow breakdown shows where IDEAYA Biosciences, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $71.10M went out.
  • Fiscal year ended 2025-12-31: from investing, $69.98M came in.
  • Fiscal year ended 2025-12-31: from financing, $29.78M came in.
  • Fiscal year ended 2025-12-31: change in cash, $28.66M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$71.10M$69.98M$0.00$29.78M*$28.66M
2024-12-31-$247.58M-$502.56M$274.35M$403.20M*-$72.59M
2023-12-31-$115.22M-$158.46M$281.17M$81.55M*$89.04M
2022-12-31-$87.17M-$33.40M$86.11M$11.06M*-$23.41M
2021-12-31-$55.78M-$69.67M$85.99M$59.46M*$20.01M
2020-12-31$55.46M-$146.24M$100.66M$28.09M*$37.97M
2019-12-31-$39.31M$2.27M$50.32M$13.56M
2018-12-31-$27.62M-$63.18M$91.00K$105.29M*$14.58M
2017-12-31-$12.22M-$8.93M$226.00K$17.26M*-$3.66M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$88.21M*-$155.93M*$851.00K*$358.36M*
2026-03-31-$75.17M$118.95M$1.19M$44.96M
2025-12-31-$90.50M*-$97.53M*$1.50M*$627.00K*
2025-09-30$142.21M*$41.77M*$384.00K*
2025-06-30-$62.47M*$45.92M*$410.00K*$795.00K*
2025-03-31-$60.34M$79.82M$1.13M$25.01M*$45.62M
2024-12-31-$121.66M*-$197.11M*-$340.00K*$3.09M*
2024-09-30-$49.23M*-$20.04M*$274.69M*$11.81M*
2024-06-30-$32.88M*$68.56M*$2.08M*$37.10M*
2024-03-31-$43.81M-$353.97M$343.65M$5.46M*-$48.67M
2023-12-31-$23.75M*-$111.94M*$127.57M*$13.32M*
2023-09-30-$30.17M*$51.35M*-$249.00K*$28.08M*
2023-06-30-$33.46M*-$121.38M*$151.28M*$39.78M*
2023-03-31-$27.84M$23.52M$2.56M-$1.40M
2022-12-31-$23.37M*-$10.28M*-$375.00K*
2022-09-30-$24.17M*-$18.68M*$86.48M*$9.22M*
2022-06-30-$19.99M*$13.32M*-$227.00K*
2022-03-31-$19.65M-$17.76M$662.00K-$36.76M
2021-12-31-$16.66M*-$413.00K*$0.00*$688.00K*
2021-09-30-$12.47M*-$56.31M*$808.00K*$85.97M*
2021-06-30-$12.93M*-$49.38M*$243.00K*$15.74M*
2021-03-31-$13.72M$36.44M$112.00K$41.89M*$64.72M
2020-12-31-$11.60M*-$4.55M*$0.00*$6.95M*
2020-09-30$90.21M*-$183.58M*$6.79M*$20.28M*
2020-06-30-$13.61M*$30.99M*$692.00K*$94.01M*
2020-03-31-$9.54M$10.91M$34.00K$1.40M
2019-12-31-$8.71M*$3.89M*$0.00*
2019-09-30-$10.55M*-$38.44M*-$460.00K*
2019-06-30-$10.27M*$11.41M*$66.00K*$51.61M*
2019-03-31-$9.79M$25.41M$1.00K-$827.00K*$14.80M
2018-12-31-$7.48M*$6.58M*-$6.00K*
2018-09-30-$8.69M*$5.26M*$41.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53